Andreas Roos

Adjunct Professor, University of Ottawa

Scientific Officer, Department of Neuropediatrics, University Hospital Essen

Email Andreas

Andreas completed his PhD in 2009 with Professor Jan Senderek in the Neurogenetics group of the Institute of Human Genetics of RWTH-Aachen University in Germany, where his thesis focused on the elucidation of molecular and biochemical mechanisms in autosomal recessive Charcot-Marie-Tooth neuropathies. Following a postdoc in the Institute of Molecular Biology and Medical Biochemistry at the University of Saarland, he became a junior group leader at the Institute of Neuropathology at RWTH-Aachen University. Subsequently, he took on the role of group lead of the Tissue Omics group at the Leibniz Institute of Analytical Science (ISAS) in Dortmund, focusing on applied proteomics toward a better understanding of the molecular genesis of neuromuscular diseases. In 2015 he moved to Newcastle upon Tyne (UK) as Scientific Officer in the John Walton Muscular Dystrophy Research Centre under Professor Hanns Lochmüller. After moving to Essen in Germany in 2018 to become Scientific Officer in the  University Hospital Essen’s Department of Neuropediatrics, together with Prof. Ulrike Schara he was awarded a 2.9M Euro grant from the European Regional Development Fund for NMD-GPS, a major interdisciplinary multi-omics project aiming to improve the diagnostic management of patients with neuromuscular diseases as well as to group these diseases according to their underlying pathomechanisms.

In 2019 Andreas was awarded an adjunct professorship at the University of Ottawa, where he will be an external/visiting member of the Lochmüller Lab team, teaching applied proteomics in the context of neuromuscular diseases, co-supervising students and continuing his many close scientific collaborations with the group.

Dr. Andreas Roos

Read more about Andreas

Recent publications

Töpf, A, Pyle, A, Griffin, H, Matalonga, L, Schon, K, Solve-RD SNV-indel working group et al.. Exome reanalysis and proteomic profiling identified TRIP4 as a novel cause of cerebellar hypoplasia and spinal muscular atrophy (PCH1). Eur J Hum Genet. 2021. PMID:34075209

Mohassel, P, Donkervoort, S, Lone, MA, Nalls, M, Gable, K, Gupta, SD et al.. Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis. Nat Med. 2021. PMID:34059824

Kölbel, H, Preuße, C, Brand, L, von Moers, A, Della Marina, A, Schuelke, M et al.. Inflammation, fibrosis and skeletal muscle regeneration in LGMDR9 are orchestrated by macrophages. Neuropathol Appl Neurobiol. 2021. PMID:33973272

Sicking, M, Lang, S, Bochen, F, Roos, A, Drenth, JPH, Zakaria, M et al.. Complexity and Specificity of Sec61-Channelopathies: Human Diseases Affecting Gating of the Sec61 Complex. Cells. 2021.10 (5) PMID:33925740

Hathazi, D, Cox, D, D'Amico, A, Tasca, G, Charlton, R, Carlier, RY et al.. INPP5K and SIL1 associated pathologies with overlapping clinical phenotypes converge through dysregulation of PHGDH. Brain. 2021. PMID:33792664

Straka, T, Schröder, C, Roos, A, Kollipara, L, Sickmann, A, Williams, MPI et al.. Regulatory Function of Sympathetic Innervation on the Endo/Lysosomal Trafficking of Acetylcholine Receptor. Front Physiol. 2021.12 626707 PMID:33776791

Grande, V, Hathazi, D, O Connor, E, Marteau, T, Schara-Schmidt, U, Hentschel, A et al.. Dysregulation of GSK3β-Target Proteins in Skin Fibroblasts of Myotonic Dystrophy Type 1 (DM1) Patients. J Neuromuscul Dis. 2021. PMID:33682722

Hentschel, A, Czech, A, Münchberg, U, Freier, E, Schara-Schmidt, U, Sickmann, A et al.. Protein signature of human skin fibroblasts allows the study of the molecular etiology of rare neurological diseases. Orphanet J Rare Dis. 2021.16 (1)73 PMID:33563298

Gungor, S, Oktay, Y, Hiz, S, Aranguren-Ibáñez, Á, Kalafatcilar, I, Yaramis, A et al.. Autosomal recessive variants in TUBGCP2 alter the γ-tubulin ring complex leading to neurodevelopmental disease. iScience. 2021.24 (1)101948 PMID:33458610

Kohlschmidt, N, Elbracht, M, Czech, A, Häusler, M, Phan, V, Töpf, A et al.. Molecular pathophysiology of human MICU1 deficiency. Neuropathol Appl Neurobiol. 2021. PMID:33428302

Gangfuß, A, Yigit, G, Altmüller, J, Nürnberg, P, Czeschik, JC, Wollnik, B et al.. Intellectual disability associated with craniofacial dysmorphism, cleft palate, and congenital heart defect due to a de novo MEIS2 mutation: A clinical longitudinal study. Am J Med Genet A. 2021.185 (4)1216-1221 PMID:33427397

Spendiff, S, Howarth, R, McMacken, G, Davey, T, Quinlan, K, O'Connor, E et al.. Modulation of the Acetylcholine Receptor Clustering Pathway Improves Neuromuscular Junction Structure and Muscle Strength in a Mouse Model of Congenital Myasthenic Syndrome. Front Mol Neurosci. 2020.13 594220 PMID:33390901

See more on PubMed